Larazotide is an octapeptide inhibitor of paracellular permeability whose structure is derived from a protein (zonula occludens toxin) secreted by Vibrio cholerae for treatment of Coeliac disease.
CAT No: R1967
CAS No:258818-34-7
Synonyms/Alias:Larazotide;258818-34-7;Larazotida;Larazotide [USAN:INN];AT 2347;AT-2347;ZN3R5560ZV;2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid;DTXSID30180526;258818-34-7 (free base);glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycine;larazotidum;UNII-ZN3R5560ZV;larazotide-acetate;2-(((2S)-1-((2S)-2-((2S)-2-((2S)-2-((2S)-2-(2-(2-aminoacetamido)acetamido)-3-methylbutanamido)-4-methylpentanamido)-3-methylbutanamido)-4-carbamoylbutanoyl)pyrrolidin-2-yl)formamido)acetic acid;2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid;Larazotide [INN];Larazotide (USAN/INN);LARAZOTIDE [USAN];LARAZOTIDE [WHO-DD];CHEMBL2105646;SCHEMBL23668120;DTXCID70103017;CHEBI:177799;ORFLZNAGUTZRLQ-ZMBVWFSWSA-N;AKOS040741937;DB05645;H-Gly-Gly-Val-Leu-Val-Gln-Pro-Gly-OH;DA-54793;HY-106268;CS-0025478;NS00072884;D09351;Q27295752;Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-;2-((S)-1-((2S,5S,8S,11S)-17-Amino-2-(3-amino-3-oxopropyl)-8-isobutyl-5,11-diisopropyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaheptadecan-1-oyl)pyrrolidine-2-carboxamido)acetic acid;
Chemical Name:2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More